Zobrazeno 1 - 10 of 25 pro vyhledávání: '"E. Bolonaki"'
1
Altering interface detector positioning in combination with prestorage filtration to achieve a better quality of single donor platelet concentrates using the CS 3000 Plus blood separator
Autor: E. Kandidaki, E. Nikoloudi, D. Mavroudis, E. Lydaki, E. Bolonaki
Publikováno v: Journal of clinical apheresis. 17(1)
The interface detector (ID) is an optical density sensor that affects the quality of single donor platelet collection using the CS 3000 Plus blood separator. The purpose of this study was to evaluate the effect of altering ID position on platelet yie
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36f8f6f01a615b70c9c16747e7de7169
https://pubmed.ncbi.nlm.nih.gov/11948702
Zobrazit plný text záznamu
2
Congenital systemic Langerhans cell histiocytosis (report of two cases)
Autor: E, Stiakaki, C, Giannakopoulou, E, Kouvidi, E, Bolonaki, A, Kambourakis, E, Lydaki, M, Kalmanti
Publikováno v: Haematologia. 28(4)
Two cases of congenital systemic Langerhans cell histiocytosis (LCH), diagnosed and treated in our department from June 1995 until May 1996, are described. The cases concern two neonates (one female and one male) born with necrotic lesions and skin n
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b0bc3f15c04d607b30daa798ee7428e7
https://pubmed.ncbi.nlm.nih.gov/9408765
Zobrazit plný text záznamu
3
Merocyanine 540 mediated photoirradiation of leukemic cells. In vitro inference on cell survival
Autor: E. Bolonaki, Maria Kalmanti, T.-H. Papazoglou, E. Lydaki, Helen Dimitriou
Publikováno v: Journal of photochemistry and photobiology. B, Biology. 32(1-2)
In order to evaluate the selective killing of merocyanine 540 (MC 540) mediated photoirradiation in neoplastic cells, bone narrow cells from children with leukaemia or neuroblastoma and normal children as well as peripheral blood cells and Reh-6 and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c96da69b0cab0ec3d248eb456650d273
https://pubmed.ncbi.nlm.nih.gov/8725050
Zobrazit plný text záznamu
4
Efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte-macrophage colony-stimulating factor in neutropenic children with malignancies
Autor: Maria Kalmanti, Eftichia Stiakaki, E. Bolonaki, Helen Dimitriou, E. Lydaki, Th. Kalmantis
Publikováno v: Pediatric hematology and oncology. 12(6)
The difference between the effects of administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF) and recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) was studied in 39 children with neutropenia se
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c332b8ae94c4f6c007c6a95bbd25e524
https://pubmed.ncbi.nlm.nih.gov/8589000
Zobrazit plný text záznamu
5
Proliferating cell nuclear antigen (PCNA) expression in childhood lymphomas
Autor: M, Kalmanti, P, Kanavaros, A, Sakalidou, M, Tzardi, G, Datseris, E, Bolonaki, T, Kalmantis, E, Kazlaris, G, Delides
Publikováno v: Acta morphologica Hungarica. 40(1-4)
Paraffin sections from 21 cases of Hodgkin's disease (HD) and 28 cases (26 high-grade and 2 low-grade) of non-Hodgkin's lymphomas (NHL) occurring in childhood were examined for the presence of proliferating cell nuclear antigen using an anti-PCNA ant
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::dfda28c0096c60008627485c1c917224
https://pubmed.ncbi.nlm.nih.gov/1365765
Zobrazit plný text záznamu
7
Vaccination of patients with advanced non-small cell lung cancer with an optimized cryptic hTERT peptide (Vx-001)
Autor: D. Mavroudis, E. Bolonaki, A. Kotsakis, A. Vagia, E. Papadimitraki, V. Georgoulias, G. Kosnoslakis, Kostas Kosmatopoulos, D. Agouraki, Charalambos Christophylakis
Publikováno v: Journal of Clinical Oncology. 25:7642-7642
7642 Background: To evaluate the immunological and clinical efficacy of the optimized peptide TERT572Y (Vx-001) presented by HLA-A*0201 in patients with advanced non-small cell lung cancer (NSCLC). Methods: Twenty-two patients with residual (n=8) or
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::584f09cd39d07d1bee2da94a85ac7479
https://doi.org/10.1200/jco.2007.25.18_suppl.7642
Zobrazit plný text záznamu
8
Clinical efficacy and immunogenicity of the optimized cryptic peptide TERT572Y vaccine (Vx-001) in patients with advanced non-small cell lung cancer (NSCLC)
Autor: E. Bolonaki, E. Papadimitraki, D. Mavroudis, A. Kotsakis, V. Georgoulias, Kostas Kosmatopoulos, E. Nikoloudi, Despoina Aggouraki, P. Kanellou
Publikováno v: Journal of Clinical Oncology. 24:17069-17069
17069 Background: BTERT572Y, an optimized cryptic peptide homologous to TERT induces efficient antitumoral T cell cytotoxic immunity but not autoreactivity in vivo in HLA-A*0201 transgenic mice and healthy blood donors and prostate cancer patients (J
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b9986c366611c942e404206aac6e1202
https://doi.org/10.1200/jco.2006.24.18_suppl.17069
Zobrazit plný text záznamu
9
Safety and immunogenicity of the optimized cryptic peptide TERT572Y in patients with advanced malignancies: A Phase I clinical study
Autor: E. Nikoloudi, C. H. Christophillakis, M. Spiropoulou, P. Kanellou, E. Bolonaki, I. Miconnet, V. Georgoulias, Kostas Kosmatopoulos, S. Cornet, D. Mavroudis, G. Millaki
Publikováno v: Journal of Clinical Oncology. 23:2579-2579
2579 Background: TERT572Y, an optimized cryptic peptide homologous to TERT induces efficient antitumoral T cell cytotoxic immunity but not autoreactivity in vivo in HLA-A*0201 transgenic mice and h...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0adc9139dd67a5ac6d952cee94339ec3
https://doi.org/10.1200/jco.2005.23.16_suppl.2579
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje